A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 … – BMC Medicine

Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic. https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed 28 May 2023.

Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, et al. A multinational Delphi consensus to end the COVID-19 public health threat. Nature. 2022;611:33245.

Article CAS PubMed PubMed Central Google Scholar

Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22:1293302.

Article CAS PubMed PubMed Central Google Scholar

Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624.

Article PubMed PubMed Central Google Scholar

Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021. https://doi.org/10.1016/S0140-6736(21)00306-8.

Article PubMed PubMed Central Google Scholar

Bollyky TJ, Gostin LO, Hamburg MA. The Equitable distribution of COVID-19 therapeutics and vaccines. JAMA. 2020;323:24623.

Article CAS PubMed Google Scholar

Fair allocation mechanism for COVID-19 vaccines through the COVAX Facility. https://www.who.int/publications/m/item/fair-allocation-mechanism-for-covid-19-vaccines-through-the-covax-facility. Accessed 28 May 2023.

Wiysonge CS, Ndwandwe D, Ryan J, Jaca A, Batour O, Anya B-PM, et al. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future? Hum Vaccin Immunother. 2022;18:13.

Article CAS PubMed Google Scholar

Vilches TN, Moghadas SM, Sah P, Fitzpatrick MC, Shoukat A, Pandey A, et al. Estimating COVID-19 Infections, hospitalizations, and deaths following the US Vaccination campaigns during the pandemic. JAMA Netw Open. 2022;5:e2142725.

Article PubMed PubMed Central Google Scholar

Jia KM, Hanage WP, Lipsitch M, Johnson AG, Amin AB, Ali AR, et al. Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States. Eur J Epidemiol. 2023;24:14.

Mesl MM, Brown J, Mook P, Hagan J, Pastore R, Bundle N, et al. Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021. Euro Surveill. 2021;26:2101021

Liu Y, Procter SR, Pearson CAB, Montero AM, Torres-Rueda S, Asfaw E, et al. Assessing the impacts of COVID-19 vaccination programmes timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries. BMC Med. 2023;21:85.

Article PubMed PubMed Central Google Scholar

Sah P, Vilches TN, Moghadas SM, Fitzpatrick MC, Singer BH, Hotez PJ, et al. Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants. EClinicalMedicine. 2021;35:100865.

Article PubMed PubMed Central Google Scholar

Bauer S, Contreras S, Dehning J, Linden M, Iftekhar E, Mohr SB, et al. Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves. PLoS Comput Biol. 2021;17:e1009288.

Article CAS PubMed PubMed Central Google Scholar

Ferreira LS, Darcie Marquitti FM, Paixo da Silva RL, Borges ME, Ferreira da Costa Gomes M, Cruz OG, et al. Estimating the impact of implementation and timing of the COVID-19 vaccination programme in Brazil: a counterfactual analysis. Lancet Reg Health Am. 2023;17:100397.

Mathieu E, Ritchie H, Rods-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus pandemic (COVID-19). Our World in Data. 2020. Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/coronavirus.

Ghafari M, Kadivar A, Katzourakis A. Excess deaths associated with the Iranian COVID-19 epidemic: a province-level analysis. Int J Infect Dis. 2021;107:10115.

Article CAS PubMed PubMed Central Google Scholar

Callaway E. The unequal scramble for coronavirus vaccines - by the numbers. Nature. 2020;584:5067.

Article CAS PubMed Google Scholar

Dyer O. COVID-19: Countries are learning what others paid for vaccines. BMJ. 2021;372:n281.

Article PubMed Google Scholar

Ghafari M, Rezaee-Zavareh MS, Dascalu S, Katzourakis A. Irans COVID-19 vaccination programme: using transparency to build public trust in immunisation. The BMJ. 2021. https://blogs.bmj.com/bmj/2021/08/03/irans-covid-19-vaccination-programme-using-transparency-to-build-public-trust-in-immunisation/. Accessed 28 May 2023.

Iran bans import of UK and US COVID-19 vaccines, saying theyre completely untrustworthy. France 24. 2021. https://www.france24.com/en/middle-east/20210109-iran-bans-import-of-uk-and-us-covid-19-vaccines-saying-they-re-completely-untrustworthy. Accessed 28 May 2023.

Iran receives first delivery of COVID-19 vaccines through COVAX facility. https://www.unicef.org/iran/en/press-releases/iran-receives-first-delivery-covid-19-vaccines-through-covax-facility. Accessed 31 May 2023.

The first shipment of COVAX vaccines. https://www.unicef.org/supply/stories/first-shipment-covax-vaccines. Accessed 31 May 2023.

First COVID-19 vaccines arrive in Malawi thanks to COVAX Facility. https://www.eeas.europa.eu/eeas/first-covid-19-vaccines-arrive-malawi-thanks-covax-facility_en. Accessed 31 May 2023.

Royal Society Expert Working Group. COVID-19: examining the effectiveness of non-pharmaceutical interventions. 2023.

Ghafari M, Hejazi B, Karshenas A, Dascalu S, Kadvidar A, Khosravi MA, et al. Lessons for preparedness and reasons for concern from the early COVID-19 epidemic in Iran. Epidemics. 2021;36:100472.

Article CAS PubMed PubMed Central Google Scholar

WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/. Accessed 31 May 2023.

United Nations: Department of Economic and Social Affairs. World economic situation and prospects. New York. NY: United Nations; 2020. p. 2020.

Google Scholar

COVID-19 market dashboard. https://www.unicef.org/supply/covid-19-market-dashboard. Accessed 31 May 2023.

United Nations: Department of Economic and Social Affairs. World economic situation and prospects. New York. NY: United Nations; 2021. p. 2021.

Google Scholar

United Nations: Department of Economic and Social Affairs. World economic situation and prospects. New York. NY: United Nations; 2022. p. 2022.

Google Scholar

Ghafari M, Watson OJ, Karlinsky A, Ferretti L, Katzourakis A. A framework for reconstructing SARS-CoV-2 transmission dynamics using excess mortality data. Nat Commun. 2022;13:3015.

Article CAS PubMed PubMed Central Google Scholar

Al Kaabi N, Oulhaj A, Ganesan S, Al Hosani FI, Najim O, Ibrahim H, et al. Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi. United Arab Emirates Nat Commun. 2022;13:3215.

PubMed Google Scholar

Safavi-Naini SAA, Pourhoseingholi MA. The early impact of COVID-19 vaccination on deaths among elderly people in Iran. Gastroenterol Hepatol Bed Bench. 2022;15:1035.

PubMed PubMed Central Google Scholar

Baptista Risi J, Jr. The control of poliomyelitis in Brazil. Rev Infect Dis. 1984;6(Suppl 2):S4003.

Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS. Strategies for mitigating an influenza pandemic. Nature. 2006;442:44852.

Article CAS PubMed PubMed Central Google Scholar

Noh J-W, Kim Y-M, Akram N, Yoo KB, Cheon J, Lee LJ, et al. Determinants of timeliness in early childhood vaccination among mothers with vaccination cards in Sindh province, Pakistan: a secondary analysis of cross-sectional survey data. BMJ Open. 2019;9:e028922.

Article PubMed PubMed Central Google Scholar

COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet. 2022;399:146988.

Article PubMed Central Google Scholar

ODriscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, et al. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2020. https://doi.org/10.1038/s41586-020-2918-0.

Article PubMed Google Scholar

Sandmann FG, Jit M. Rapid COVID-19 vaccine rollout: immense success but challenges ahead. Lancet Infect Dis. 2022;22:3024.

Article CAS PubMed Google Scholar

Suthar AB, Wang J, Seffren V, Wiegand RE, Griffing S, Zell E. Public health impact of COVID-19 vaccines in the US: observational study. BMJ. 2022;377:e069317.

Article PubMed Google Scholar

Ghafari M, Kadivar A, Katzourakis A. Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran. The Lancet Infectious Diseases. 2021;21:6023

Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613:1307.

Article CAS PubMed Google Scholar

Karlinsky A, Kobak D. Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset. Elife. 2021;10:e69336.

Torbati Y. Amid covid surge, Iran cut corners to approve yet-unproven vaccine. The Washington Post. 2022. https://www.washingtonpost.com/world/2022/08/20/iran-covid-vaccine-approval/.

Rovetta A, Garavaglia R, Vitale A, Meccia E, Tesfaye BT, Mezzana P, et al. An improved peer-review system to compensate for scientific misconduct in health-sensitive topics. 2022;44:1605601.

Negotiating with major vaccine manufacturers in the world [Persian]. https://dolat.ir/detail/344397. Accessed 31 May 2023.

Mok CKP, Cohen CA, Cheng SMS, Chen C, Kwok K-O, Yiu K, et al. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong. Respirology. 2022;27:30110.

Article PubMed Google Scholar

Premikha M, Chiew CJ, Wei WE, Leo YS, Ong B, Lye DC, et al. Comparative effectiveness of mRNA and inactivated whole-virus vaccines against Coronavirus disease 2019 infection and severe disease in Singapore. Clin Infect Dis. 2022;75:14425.

Article CAS PubMed Google Scholar

Tan CY, Chiew CJ, Lee VJ, Ong B, Lye DC, Tan KB. Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among elderly in Singapore. Lancet Reg Health West Pac. 2022;29:100654.

Article PubMed PubMed Central Google Scholar

Au WY, Cheung PP-H. Effectiveness of heterologous and homologous COVID-19 vaccine regimens: living systematic review with network meta-analysis. BMJ. 2022;377:e069989.

Article PubMed Google Scholar

Mostafavi E, Eybpoosh S, Karamouzian M, Khalili M, Haji-Maghsoudi S, Salehi-Vaziri M, et al. Efficacy and safety of a protein-based SARS-CoV-2 vaccine: a randomized clinical trial. JAMA Netw Open. 2023;6:e2310302.

Article PubMed PubMed Central Google Scholar

Iranian Registry of Clinical Trials (IRCT). https://www.irct.ir/trial/54833. Accessed 29 May 2023.

Islam MR, Hasan M, Nasreen W, Tushar MI, Bhuiyan MA. The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study. Int J Immunopathol Pharmacol. 2021;35:20587384211065628.

Article CAS PubMed PubMed Central Google Scholar

Kansakar S, Dumre SP, Raut A, Huy NT. From lockdown to vaccines: challenges and response in Nepal during the COVID-19 pandemic. Lancet Respir Med. 2021;9:6945.

Article CAS PubMed PubMed Central Google Scholar

Calleja N, Gualtieri A, Terzic N, Scoutellas V, Calleja-Agius J. Managing COVID-19 in four small countries: initial response to the pandemic in San Marino, Montenegro. Malta and Cyprus Health Policy. 2022;126:2816.

Article PubMed Google Scholar

Universal Declaration on bioethics and Human Rights. 2005. https://www.unesco.org/en/legal-affairs/universal-declaration-bioethics-and-human-rights?hub=66535. Accessed 10 Jun 2023.

Covid-19 Update: Islamic Republic of Iran (No. 832 / 31 May 2022). World Health Organization - Regional Office for the Eastern Mediterranean. http://www.emro.who.int/iran.

Hodcroft E. CoVariants: SARS-CoV-2 mutations and variants of interest. https://covariants.org/. Accessed 18 Jan 2023.

More:

A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 ... - BMC Medicine